• Dovitinib (TKI-258): Advancing RTK-Driven Cancer Workflows

  2026-06-23

  Dovitinib (TKI-258, CHIR-258) delivers potent, multitargeted RTK inhibition, empowering researchers to dissect and modulate key signaling pathways in cancer models with high precision. This guide translates bench-validated protocols, troubleshooting strategies, and recent cheminformatics advances into actionable workflows—maximizing both reproducibility and biological insight.

• lncRNA HNF4A-AS1 Modulates Sorafenib Resistance via Lipid Me

  2026-06-23

  This study uncovers how decreased lncRNA HNF4A-AS1 expression in hepatocellular carcinoma (HCC) cells leads to resistance against sorafenib-induced ferroptosis by reprogramming lipid metabolism. The findings highlight a novel regulatory axis involving HNF4A-AS1, m6A-modified DECR1 mRNA, and polyunsaturated fatty acid (PUFA) dynamics, suggesting potential targets for overcoming treatment resistance in liver cancer.

• TCAIM-Mediated Control of OGDH Levels Shapes Mitochondrial M

  2026-06-22

  Wang et al. reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds and reduces α-ketoglutarate dehydrogenase (OGDH) protein levels via HSPA9 and LONP1, providing a new mechanism for post-translational metabolic regulation. This study highlights a targeted approach to modulating mitochondrial enzyme abundance, with significant implications for understanding and manipulating cellular energy metabolism.

• YAP-TEAD Drives PPARα-Induced Liver Regeneration via WY-1464

  2026-06-22

  This study establishes the YAP-TEAD transcriptional module as essential for PPARα-driven hepatomegaly and liver regeneration in mice, using the selective agonist WY-14643 (Pirinixic Acid). These findings clarify mechanistic links between nuclear receptor signaling and regenerative pathways, informing targeted metabolic and hepatic research.

• Applied Workflows with LY-411575: Gamma-Secretase Inhibition

  2026-06-21

  LY-411575, a potent gamma-secretase inhibitor, is redefining experimental precision in Alzheimer's and cancer research through its dual modulation of amyloid beta and Notch pathways. This guide delivers actionable protocols, troubleshooting insights, and a unique translation of reference findings to maximize research impact with APExBIO's LY-411575.

• Streptavidin-FITC: Optimizing Biotin Detection in LNP Traffi

  2026-06-20

  Explore how Streptavidin-FITC empowers precision detection of biotinylated molecules in lipid nanoparticle (LNP) trafficking studies. This article uniquely bridges advanced assay design with mechanistic insights from recent research, highlighting practical protocols and APExBIO’s innovation.

• ω-Agatoxin IVA TFA: Strategic Innovation in Cav2.1 Blockade

  2026-06-19

  This thought-leadership article dissects the mechanistic and translational value of ω-Agatoxin IVA TFA, a nanomolar-potency P/Q-type calcium channel blocker. By uniting biological insight, rigorous validation, and actionable guidance for advanced neurophysiology, the piece maps out new frontiers in synaptic transmission research, epilepsy modeling, and neuroprotection. Contextual evidence, including findings from Sidach & Mintz and contemporary workflow literature, grounds recommendations for translational researchers. APExBIO’s product is positioned as a paradigm-shifting tool for precision neuroscience.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-06-19

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides a reliable, visible molecular weight standard for SDS-PAGE and Western blotting, with defined color bands for clear monitoring and transfer assessment. It is best suited to workflows requiring EDTA-free reagents, phosphoprotein compatibility, and fluorescent membrane imaging, but is not appropriate where direct paper-validated quantitative calibration is critical.

• Optimizing Cancer Assays with Dovitinib (TKI-258, CHIR-258)

  2026-06-18

  This in-depth guide addresses laboratory challenges in cell viability and signal transduction assays, highlighting how Dovitinib (TKI-258, CHIR-258) (SKU A2168) delivers reproducible, data-driven results across cancer research models. Evidence-backed protocol advice and practical vendor comparisons help ensure high-fidelity RTK inhibition and reliable apoptosis induction.

• HyperTrap Heparin HP Column: Advancing High-Resolution Stemn

  2026-06-18

  The HyperTrap Heparin HP Column transforms affinity chromatography by enabling high-resolution purification of complex biomolecules, including stemness regulators implicated in cancer progression. Its robust design and advanced HyperChrom Heparin HP Agarose medium empower researchers to dissect signaling pathways like CCR7–Notch1 with precision, bridging cutting-edge bench research with translational impact.

• Balsalazide Disodium: Optimizing Inflammation Research Proto

  2026-06-17

  Balsalazide Disodium Dihydrate empowers researchers with targeted, water-soluble anti-inflammatory action, making it a benchmark for robust inflammation and IBD model assays. This guide translates radiolabeling breakthroughs and protocol refinements into actionable workflows for high-fidelity preclinical discovery.

• Selective Autophagy Regulates IRF3 Stability and IFN Balance

  2026-06-17

  The reference study uncovers how selective autophagy, mediated by CALCOCO2/NDP52 and regulated by the deubiquitinase PSMD14, modulates the stability of IRF3—a key transcription factor in type I interferon signaling—during antiviral responses. This mechanistic insight refines our understanding of immune homeostasis and highlights targets for precise modulation of innate immunity.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-06-16

  This study reveals a mechanistic link between carcinogen-induced super-enhancer RNA (seRNA-NPCm) and increased metastasis in nasopharyngeal carcinoma (NPC). By dissecting the NPM1/c-Myc/NDRG1 regulatory axis, the research highlights new molecular targets and provides a robust roadmap for translational cancer biology.

• Ceftolozane Sulfate: Accelerating PK/PD Antibacterial Resear

  2026-06-16

  Ceftolozane sulfate delivers robust, reproducible bactericidal activity against Pseudomonas aeruginosa and resistant Enterobacterales, with exceptional stability against AmpC β-lactamases. This article details advanced research protocols, troubleshooting strategies, and insights for maximizing translational impact, leveraging APExBIO's high-purity Ceftolozane sulfate.

• ZCL278: Selective Cdc42 Inhibitor for Cell Motility Studies

  2026-06-15

  ZCL278 empowers researchers to dissect Cdc42-mediated pathways with precision, enabling breakthrough insights in cell motility and neuronal development. This guide delivers actionable protocols, troubleshooting advice, and highlights from the latest Cdc42-targeting fibrosis research.

14654 records 1/977 page Next 12345 下5页 Last page